Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ru Zhang, Qing Guan, Mengting Zhang, Yajie Ding, Zongzhe Tang, Hongliang Wang, Wei Zhang, Yue Chen, Rong Jiang, Yan Cui & Jie Wang. (2022) Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study. Diabetes, Metabolic Syndrome and Obesity 15, pages 3167-3179.
Read now
Read now
Aki Juhani Käräjämäki, Arto Korkiakoski, Janne Hukkanen, Y. Antero Kesäniemi & Olavi Ukkola. (2022) Long-term metabolic fate and mortality in obesity without metabolic syndrome. Annals of Medicine 54:1, pages 1432-1443.
Read now
Read now
Chenyi Wang, Qianglong Niu, Haihong Lv, Qian Li, Yuping Ma, Jiaojiao Tan & Chunhua Liu. (2020) Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study. Diabetes, Metabolic Syndrome and Obesity 13, pages 4369-4378.
Read now
Read now
Keyu Yang, Xiaowei Zhang, Yong Zhou, Fu Chen, Mingyang Shen & Yong Wang. (2020) Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 13, pages 1459-1464.
Read now
Read now
Paweł Małecki, Joanna Tracz, Magdalena Łuczak, Magdalena Figlerowicz, Katarzyna Mazur-Melewska, Wojciech Służewski & Anna Mania. (2020) Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. Expert Review of Proteomics 17:7-8, pages 623-632.
Read now
Read now
Aki Juhani Käräjämäki, Janne Hukkanen, Heikki Kauma, Y. Antero Kesäniemi & Olavi Ukkola. (2020) Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). Scandinavian Journal of Clinical and Laboratory Investigation 80:2, pages 106-113.
Read now
Read now
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo & Giampiero Francica. (2019) A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology 13:7, pages 667-681.
Read now
Read now
Yi Chen, Ningjian Wang, Yingchao Chen, Qin Li, Bing Han, Chi Chen, Hualing Zhai & Yingli Lu. (2018) The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: A new insight from SPECT-China study. Autoimmunity 51:5, pages 238-244.
Read now
Read now
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher & Amedeo Lonardo. (2018) Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 12:4, pages 351-367.
Read now
Read now
Giampiero Francica. (2017) Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. Journal of Hepatocellular Carcinoma 4, pages 23-27.
Read now
Read now
Sven Francque & Luisa Vonghia. (2017) The future of diagnosing NASH - could a simple blood test be the key?. Expert Review of Gastroenterology & Hepatology 11:11, pages 995-997.
Read now
Read now
Simona Cernea, Avivit Cahn & Itamar Raz. (2017) Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. Expert Review of Clinical Pharmacology 10:5, pages 535-547.
Read now
Read now
Articles from other publishers (74)
Jiayao Huang, Jianyun Peng, Haiyi Long, Simin Ruan, Lu Yao, Xiaoyan Xie, Manxia Lin & Xiaoer Zhang. (2024) Feasibility and Measurement Value of Pancreatic 2-D Shear Wave Elastography in Healthy Adults: Evaluation, Influencing Factors, Reference Range, Measurement Stability and Reproducibility. Ultrasound in Medicine & Biology 50:2, pages 184-190.
Crossref
Crossref
Yanan Zhao, Chen Qiu, Yiping Dong, Xuchu Wang, Jifan Chen, Jianting Yao, Yifan Jiang, Chao Zhang, Huifang Weng, Yajing Liu, Yik-Ning Wong & Pintong Huang. (2023) Technical Acoustic Measurements Combined with Clinical Parameters for the Differential Diagnosis of Nonalcoholic Steatohepatitis. Diagnostics 13:9, pages 1547.
Crossref
Crossref
Jie Pan, Yijie Ding, Yan Sun, Qiuyan Li, Tianyi Wei, Yingying Gu, Yujia Zhou, Nengzhi Pang, Lei Pei, Sixi Ma, Mengqi Gao, Ying Xiao, De Hu, Feilong Wu & Lili Yang. (2023) Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria. Journal of Clinical Medicine 12:6, pages 2126.
Crossref
Crossref
Aki J. Käräjämäki, Janne Hukkanen & Olavi Ukkola. (2022) Pregnane X receptor gene variant rs7643645 and total mortality in subjects with nonalcoholic fatty liver disease. Pharmacogenetics and Genomics 33:2, pages 35-39.
Crossref
Crossref
Taoping Sun, Yao Deng, Xuyang Geng, Qin Fang, Xiaoqin Li, Liangkai Chen, Meixiao Zhan, Deyun Li, Kejing Zhu, Huawen Li & Liegang Liu. (2022) Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults. The Journal of Nutrition 152:4, pages 1052-1058.
Crossref
Crossref
Nimra Shahbaz, Amna Rashid, Muhammad Azzam Khan, Arshad Mehmood Naz, Hafsa Noreen, Syed Bilal Hassan & Tallat Anwar Faridi. (2022) Awareness of Augmentative and Alternative Communication among Final Semester Students of SLP. Pakistan BioMedical Journal.
Crossref
Crossref
Muhammad Areeb Shahid, Noraiz Ali, Muhammad Yousaf, Mehreen Fatima, Mian Hasnan Ahmad, Zainab Sohail, Gulshan Niaz, Areeb Sohail, Namra Yaqoob, Sania Khan & Abdur-Rehman Tuaha Mansoor. (2022) ASSOCIATION OF SONOGRAPHIC GRADING OF FATTY LIVER DISEASE WITH LIVER FUNCTION TESTS AND CT HOUNSFIELD. Pakistan BioMedical Journal 5:1.
Crossref
Crossref
Zhao-Chun Chi. (2022) Research status and progress of metabolic associated fatty liver disease. World Chinese Journal of Digestology 30:1, pages 1-16.
Crossref
Crossref
Ye Lu, Lili Hu, Jing Song, Jing Wan, Haibing Chen & Jun Yin. (2021) Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Joona Tapio, Hannu Vähänikkilä, Y. Antero Kesäniemi, Olavi Ukkola & Peppi Koivunen. (2021) Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up. Scientific Reports 11:1.
Crossref
Crossref
Sven M. Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca Dorner, Jeffrey V. Lazarus, Shira Zelber-Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, Gerardus H. Koek, Shlomo Vinker, Mehmet Ungan, Juan M. Mendive & Christos Lionis. (2021) Non-alcoholic fatty liver disease: A patient guideline. JHEP Reports 3:5, pages 100322.
Crossref
Crossref
Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Irsan Hasan, Andri Sanityoso Sulaiman & Rino Alvani Gani. (2021) Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment. European Medical Journal, pages 80-93.
Crossref
Crossref
Chloe Wong, Ming Hui Lee, Clyve Yu Leon Yaow, Yip Han Chin, Xin Lei Goh, Cheng Han Ng, Amanda Yuan Ling Lim, Mark Dhinesh Muthiah & Chin Meng Khoo. (2021) Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. Frontiers in Endocrinology 12.
Crossref
Crossref
Liwei Wu, Jingjing Li, Jiao Feng, Jie Ji, Qiang Yu, Yan Li, Yuanyuan Zheng, Weiqi Dai, Jianye Wu & Chuanyong Guo. (2021) Crosstalk between PPARs and gut microbiota in NAFLD. Biomedicine & Pharmacotherapy 136, pages 111255.
Crossref
Crossref
Sheng-Hao Zhu, Kenneth I. Zheng, Di-Shuang Hu, Feng Gao, Rafael S. Rios, Gang Li, Yang-Yang Li, Christopher D. Byrne, Giovanni Targher, Yong-Ping Chen & Ming-Hua Zheng. (2020) Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease. European Journal of Gastroenterology & Hepatology 33:3, pages 430-435.
Crossref
Crossref
Mauro Maurantonio, Filippo Gabrielli, Claudia Castellano, Andrea Carla, Pietro Andreone & Luca Roncucci. (2021) Risk factors in acute diabetic foot syndrome: analysis of 75 consecutive patients referred to a tertiary center in Modena, Italy. Exploration of Medicine.
Crossref
Crossref
Mauro Maurantonio, Filippo Gabrielli, Claudia Castellano, Andrea Carla, Pietro Andreone & Luca Roncucci. (2021) Risk factors in acute diabetic foot syndrome: analysis of 75 consecutive patients referred to a tertiary center in Modena, Italy. Exploration of Medicine.
Crossref
Crossref
Liyang Wang, MengMeng Xu, Odell D. Jones, Zhongguang Li, Yu Liang, Qiuxia Yu, Jiali Li, Yajun Wu, Xinjuan Lei, Boling He, Huimin Yue, Liqin Xiao, Rong Zhou, Wei Zhang, Xin Zhou, Yuhui Zhang, Joseph L. Bryant, Jianjie Ma, Yingli Liu & Xuehong Xu. (2020) Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy. Cell & Bioscience 10:1.
Crossref
Crossref
Jiwoo Lee, Hwi Seung Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, In Yong Bae, Chang Hee Jung, Joong-Yeol Park, Hong-Kyu Kim & Woo Je Lee. (2020) Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. Scientific Reports 10:1.
Crossref
Crossref
Stefano Ballestri, Claudio Tana, Maria Di Girolamo, Maria Cristina Fontana, Mariano Capitelli, Amedeo Lonardo & Giorgio Cioni. (2020) Semi-Quantitative Ultrasonographic Evaluation of NAFLD. Current Pharmaceutical Design 26:32, pages 3915-3927.
Crossref
Crossref
Tsung‐Po Chen, Michelle Lai, Wen‐Yuan Lin, Kuo‐Chin Huang & Kuen‐Cheh Yang. (2020) Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community‐based study. Journal of Gastroenterology and Hepatology 35:9, pages 1636-1643.
Crossref
Crossref
Lulu Wang, Xiangcheng Fan, Jichun Han, Minxuan Cai, Xiaozhong Wang, Yan Wang & Jing Shang. (2020) Gut-Derived Serotonin Contributes to the Progression of Non-Alcoholic Steatohepatitis via the Liver HTR2A/PPARγ2 Pathway. Frontiers in Pharmacology 11.
Crossref
Crossref
Hande Erman, Engin Beydogan, Seher Irem Cetin & Banu Boyuk. (2020) Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Mediators of Inflammation 2020, pages 1-7.
Crossref
Crossref
Oh-Sung Kwon, Young-Kyu Kim, Kyu Hee Her, Hyeon Ju Kim & Seung Duk Lee. (2020) Physical activity can reduce the prevalence of gallstone disease among males. Medicine 99:26, pages e20763.
Crossref
Crossref
Ling-Ling Huang, Dong-Hui Guo, Hui-Yan Xu, Song-Tao Tang, Xiao Xiao Wang, Yong-Ping Jin & Peixi Wang. (2019) Association of liver enzymes levels with fasting plasma glucose levels in Southern China: a cross-sectional study. BMJ Open 9:10, pages e025524.
Crossref
Crossref
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová & Ladislav Turecký. (2019) Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 16:19, pages 3570.
Crossref
Crossref
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, Angelo Di Vincenzo, Andrea Ticinesi, Sabina Gallina, Maria Adele Giamberardino, Francesco Cipollone, Richard Sutton, Roberto Vettor, Artur Fedorowski & Tiziana Meschi. (2019) Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. International Journal of Environmental Research and Public Health 16:17, pages 3104.
Crossref
Crossref
Young-Kyu Kim, Oh-Sung Kwon & Kyu Hee Her. (2019) The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease. Medicine 98:27, pages e16018.
Crossref
Crossref
Xu Li & Pujun Gao. (2019) Fatty liver increases gallstone disease risk in younger Chinese patients. Medicine 98:22, pages e15940.
Crossref
Crossref
Lei Luo, Ping An, Xinyong Jia, Xiaobian Yue, Sujun Zheng, Shuang Liu, Yu Chen, Wei An, Cheryl A. Winkler & Zhongping Duan. (2018) Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study. Frontiers in Genetics 9.
Crossref
Crossref
Rongjiong Zheng, Zhennan Du, Mingming Wang, Yushan Mao & Wenjie Mao. (2018) A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids in Health and Disease 17:1.
Crossref
Crossref
Michał Byra, Grzegorz Styczynski, Cezary Szmigielski, Piotr Kalinowski, Łukasz Michałowski, Rafał Paluszkiewicz, Bogna Ziarkiewicz-Wróblewska, Krzysztof Zieniewicz, Piotr Sobieraj & Andrzej Nowicki. (2018) Transfer learning with deep convolutional neural network for liver steatosis assessment in ultrasound images. International Journal of Computer Assisted Radiology and Surgery 13:12, pages 1895-1903.
Crossref
Crossref
Simona Cernea, Andrada Larisa Roiban, Emőke Both & Adina Huţanu. (2018) Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 34:8, pages e3050.
Crossref
Crossref
Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong-Yun Cha & Min-Hee Kim. (2018) Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015. Scientific Reports 8:1.
Crossref
Crossref
Preya Janubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Nigel Neil Brown, Nivene Saad, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, Anthony William Russell & Elizabeth Ellen Powell. (2018) Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications 32:8, pages 799-804.
Crossref
Crossref
Hong Cai, Sha Lu, Yueming Chen, Sayantana Das MBBS MRCOG, Zheng Niu, Guangchao Zhuo, Lei Lai & Zhifen Zhang. (2018) Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease. Clinical Biochemistry 56, pages 95-101.
Crossref
Crossref
Eun Yeong Choe, Yong-ho Lee, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Soo-Kyung Kim, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Kap Bum Huh & Zobair M Younossi. (2018) Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes. Journal of Gastroenterology and Hepatology 33:5, pages 1082-1091.
Crossref
Crossref
Soon Sun Kim, Hyo Jung Cho, Hyun Ji Kim, Dae Ryong Kang, Jacob R. Berry, Jin Hong Kim, Min Jae Yang, Sun Gyo Lim, SooJin Kim, Jae Youn Cheong & Sung Won Cho. (2018) Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. Digestive and Liver Disease 50:4, pages 370-377.
Crossref
Crossref
Donghee Kim, Goh Eun Chung, Min-Sun Kwak, Yoon Jun Kim & Jung-Hwan Yoon. (2018) Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease. Digestive and Liver Disease 50:4, pages 389-395.
Crossref
Crossref
Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, Enrica Baldelli, Simonetta Lugari, Valentina Sirotti, Valentina Giampaoli & Amedeo Lonardo. (2018) Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?. Diseases 6:1, pages 17.
Crossref
Crossref
Giovanni Targher, Amedeo Lonardo & Christopher D. Byrne. (2017) Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nature Reviews Endocrinology 14:2, pages 99-114.
Crossref
Crossref
Umberto Vespasiani-Gentilucci, Chiara Dell’Unto, Antonio De Vincentis, Andrea Baiocchini, Marco Delle Monache, Roberto Cecere, Adriano Maria Pellicelli, Valerio Giannelli, Simone Carotti, Giovanni Galati, Paolo Gallo, Francesco Valentini, Franca Del Nonno, Davide Rosati, Sergio Morini, Raffaele Antonelli-Incalzi & Antonio Picardi. (2018) Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-9.
Crossref
Crossref
William Alazawi, Eduardo Bernabe, David Tai, Tomasz Janicki, Polychronis Kemos, Salma Samsuddin, Wing-Kin Syn, David Gillam & Wendy Turner. (2017) Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLOS ONE 12:12, pages e0185902.
Crossref
Crossref
Li-Ren Wang, Yi-Fan Zhou, Yu-Jie Zhou, Shu-Hao Zhang, Wen-Yue Liu, Sheng-Jie Wu, Sven Van Poucke & Ming-Hua Zheng. (2017) Elevation of plateletcrit increasing the risk of non-alcoholic fatty liver disease development in female adults: A large population-based study. Clinica Chimica Acta 474, pages 28-33.
Crossref
Crossref
Seolhye Kim, Yoosoo Chang, Eunju Sung, Cheol Hwan Kim, Kyung Eun Yun, Hyun-Suk Jung, Hocheol Shin & Seungho Ryu. (2017) Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study. PLOS ONE 12:10, pages e0184506.
Crossref
Crossref
Andrea Armani, Alessandra Berry, Francesca Cirulli & Massimiliano Caprio. (2017) Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte. The FASEB Journal 31:10, pages 4240-4255.
Crossref
Crossref
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi & Luigi Elio Adinolfi. (2017) Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 23:36, pages 6571-6592.
Crossref
Crossref
Oliver Glass, Akash Radia, William Kraus & Manal Abdelmalek. (2017) Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease. Journal of Functional Morphology and Kinesiology 2:4, pages 35.
Crossref
Crossref
Qiao-Hua Qiao, Wen-Hua Zhu, Yun-Xian Yu, Fei-Fei Huang & Li-Ying Chen. (2017) Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine 96:38, pages e7853.
Crossref
Crossref
Namki Hong, Han Gyul Yoon, Da Hea Seo, Seho Park, Seung Il Kim, Joo Hyuk Sohn & Yumie Rhee. (2017) Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score–matched cohort study. European Journal of Cancer 82, pages 103-114.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher & Amedeo Lonardo. (2017) Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. Metabolism 72, pages 57-65.
Crossref
Crossref
Damien Viglino, Ingrid Jullian-Desayes, Mélanie Minoves, Judith Aron-Wisnewsky, Vincent Leroy, Jean-Pierre Zarski, Renaud Tamisier, Marie Joyeux-Faure & Jean-Louis Pépin. (2017) Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. European Respiratory Journal 49:6, pages 1601923.
Crossref
Crossref
Amedeo Lonardo, Fabio Nascimbeni & Maurizio Ponz de Leon. (2017) Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?. European Respiratory Journal 49:6, pages 1700546.
Crossref
Crossref
Yaru Li, Jing Wang, Yuhan Tang, Xu Han, Bing Liu, Hua Hu, Xiulou Li, Kun Yang, Jing Yuan, Xiaoping Miao, Ping Yao, Sheng Wei, Youjie Wang, Yuan Liang, Xiaomin Zhang, Huan Guo, An Pan, Handong Yang, Frank B. Hu, Tangchun Wu & Meian He. (2017) Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study. PLOS ONE 12:3, pages e0174291.
Crossref
Crossref
Aki Juhani Käräjämäki, Olli Kettunen, Samuli Lepojärvi, Olli-Pekka Koivurova, Y. Antero Kesäniemi, Heikki Huikuri & Olavi Ukkola. (2017) Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. PLOS ONE 12:3, pages e0173855.
Crossref
Crossref
Filippo Valbusa, Stefano Bonapace, Davide Agnoletti, Luca Scala, Cristina Grillo, Pietro Arduini, Emanuela Turcato, Alessandro Mantovani, Giacomo Zoppini, Guido Arcaro, Christopher Byrne & Giovanni Targher. (2017) Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. PLOS ONE 12:3, pages e0173398.
Crossref
Crossref
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri & Olavi Ukkola. (2017) Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 66, pages 55-63.
Crossref
Crossref
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang & Joo Sung Kim. (2017) Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Digestive and Liver Disease 49:1, pages 57-62.
Crossref
Crossref
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Kazuteru Mitsuhashi, Yoshitaka Hashimoto, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura & Michiaki Fukui. (2016) Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. European Journal of Gastroenterology & Hepatology 28:12, pages 1443-1449.
Crossref
Crossref
Kyung Eun Yun, Ga Eun Nam, Jisun Lim, Hye Soon Park, Yoosoo Chang, Hyun-Suk Jung, Chan-Won Kim, Byung-Joon Ko, Eun Chul Chung, Hocheol Shin & Seungho Ryu. (2016) Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study. PLOS ONE 11:7, pages e0158710.
Crossref
Crossref
A. Lonardo, S. Ballestri, D. Romagnoli & F. Nascimbeni. (2016) Alcohol and Steatosis: The Japanese Paradox. EBioMedicine 8, pages 23-24.
Crossref
Crossref
Stefano Ballestri, Stefano Zona, Giovanni Targher, Dante Romagnoli, Enrica Baldelli, Fabio Nascimbeni, Alberto Roverato, Giovanni Guaraldi & Amedeo Lonardo. (2016) Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 31:5, pages 936-944.
Crossref
Crossref
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo & Giovanni Targher. (2016) Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 61:5, pages 1246-1267.
Crossref
Crossref
Gemma Aragonès, Teresa Auguet, Sandra Armengol, Alba Berlanga, Esther Guiu-Jurado, Carmen Aguilar, Salomé Martínez, Fátima Sabench, José Porras, Maikel Ruiz, Mercé Hernández, Joan Sirvent, Daniel Del Castillo & Cristóbal Richart. (2016) PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 17:5, pages 630.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher & Amedeo Lonardo. (2016) Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 17:3, pages 355.
Crossref
Crossref
Alessandro Mantovani, Paolo Gisondi, Amedeo Lonardo & Giovanni Targher. (2016) Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?. International Journal of Molecular Sciences 17:2, pages 217.
Crossref
Crossref
Filippo Valbusa, Stefano Bonapace, Cristina Grillo, Luca Scala, Andrea Chiampan, Andrea Rossi, Giacomo Zoppini, Amedeo Lonardo, Guido Arcaro, Christopher D. Byrne & Giovanni Targher. (2016) Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure. Medicine 95:7, pages e2760.
Crossref
Crossref
Fatma Yahyaoğlu Gökmen, Süleyman Ahbab, Hayriye Esra Ataoğlu, Betül Çavuşoğlu Türker, Faik Çetin, Fatih Türker, Rabia Yahyaoğlu Mamaç & Mustafa Yenigün. (2016) FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics 71:4, pages 221-225.
Crossref
Crossref
Dong Hyun Sinn, Soo Jin Cho, Geum-Youn Gwak, Juhee Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi & Seung Woon Paik. (2016) Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis. Medicine 95:3, pages e2578.
Crossref
Crossref
Yi-Ning Dai, Jin-Zhou Zhu, Zhi-Yun Fang, De-Jian Zhao, Xing-Yong Wan, Hua-Tuo Zhu, Chao-Hui Yu & You-Ming Li. (2015) A case–control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism 64:12, pages 1667-1673.
Crossref
Crossref
Aki J. Käräjämäki, Olli-Pekka Pätsi, Markku Savolainen, Y. Antero Kesäniemi, Heikki Huikuri & Olavi Ukkola. (2015) Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLOS ONE 10:11, pages e0142937.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli & Amedeo Lonardo. (2015) Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?. Liver International 35:10, pages 2340-2341.
Crossref
Crossref
Yongyuan Zhang, Tao Zhang, Chengqi Zhang, Fang Tang, Nvjuan Zhong, Hongkai Li, Xinhong Song, Haiyan Lin, Yanxun Liu & Fuzhong Xue. (2015) Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open 5:9, pages e008204.
Crossref
Crossref
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa & Hiroshi Ito. (2015) Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLOS ONE 10:6, pages e0131138.
Crossref
Crossref